Literature DB >> 35990517

Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease.

Ryosuke Saigusa1, Payel Roy1, Antoine Freuchet1, Rishab Gulati1, Yanal Ghosheh1, Sujit Silas Armstrong Suthahar1, Christopher P Durant1, David B Hanna2, William B Kiosses1, Marco Orecchioni1, Lai Wen1, Runpei Wu1, Mark H Kuniholm3, Alan L Landay4, Kathryn Anastos5, Phyllis C Tien6, Stephen J Gange7, Seble Kassaye8, Jenifer Vallejo1, Catherine C Hedrick1, William W Kwok9, Alessandro Sette1, Howard N Hodis10,11, Robert C Kaplan2,12, Klaus Ley1,13.   

Abstract

Atherosclerosis is accompanied by a CD4 T cell response to apolipoprotein B (APOB). Major Histocompatibility Complex (MHC)-II tetramers can be used to isolate antigen-specific CD4 T cells by flow sorting. Here, we produce, validate and use an MHC-II tetramer, DRB1*07:01 APOB-p18, to sort APOB-p18-specific cells from peripheral blood mononuclear cell samples from 8 DRB1*07:01+ women with and without subclinical cardiovascular disease (sCVD). Single cell RNA sequencing showed that transcriptomes of tetramer+ cells were between regulatory and memory T cells in healthy women and moved closer to memory T cells in women with sCVD. TCR sequencing of tetramer+ cells showed clonal expansion and V and J segment usage similar to those found in regulatory T cells. These findings suggest that APOB-specific regulatory T cells may switch to a more memory-like phenotype in women with atherosclerosis. Mouse studies showed that such switched cells promote atherosclerosis.

Entities:  

Year:  2022        PMID: 35990517      PMCID: PMC9383695          DOI: 10.1038/s44161-022-00063-3

Source DB:  PubMed          Journal:  Nat Cardiovasc Res        ISSN: 2731-0590


  56 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

Review 2.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Hypoxia-inducible factors in CD4+ T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity.

Authors:  Sung Hoon Cho; Ariel L Raybuck; Julianna Blagih; Edna Kemboi; Volker H Haase; Russell G Jones; Mark R Boothby
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-15       Impact factor: 11.205

4.  Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

Authors:  M S O'Reilly; T Boehm; Y Shing; N Fukai; G Vasios; W S Lane; E Flynn; J R Birkhead; B R Olsen; J Folkman
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

5.  Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury.

Authors:  J Lohi; C L Wilson; J D Roby; W C Parks
Journal:  J Biol Chem       Date:  2000-12-19       Impact factor: 5.157

6.  Natural regulatory T cells control the development of atherosclerosis in mice.

Authors:  Hafid Ait-Oufella; Benoît L Salomon; Stéphane Potteaux; Anna-Karin L Robertson; Pierre Gourdy; Joffrey Zoll; Régine Merval; Bruno Esposito; José L Cohen; Sylvain Fisson; Richard A Flavell; Göran K Hansson; David Klatzmann; Alain Tedgui; Ziad Mallat
Journal:  Nat Med       Date:  2006-02-05       Impact factor: 53.440

Review 7.  Cytomegalovirus: Shape-Shifting the Immune System.

Authors:  Gaëlle Picarda; Chris A Benedict
Journal:  J Immunol       Date:  2018-06-15       Impact factor: 5.422

8.  Human leucocyte antigen class I and II imputation in a multiracial population.

Authors:  M H Kuniholm; X Xie; K Anastos; X Xue; L Reimers; A L French; S J Gange; S G Kassaye; A Kovacs; T Wang; B E Aouizerat; H D Strickler
Journal:  Int J Immunogenet       Date:  2016-10-24       Impact factor: 1.466

Review 9.  Regulatory T Cell Stability and Plasticity in Atherosclerosis.

Authors:  Amal J Ali; Jeffrey Makings; Klaus Ley
Journal:  Cells       Date:  2020-12-11       Impact factor: 6.600

10.  Mutations in DCHS1 cause mitral valve prolapse.

Authors:  Ronen Durst; Kimberly Sauls; David S Peal; Annemarieke deVlaming; Katelynn Toomer; Maire Leyne; Monica Salani; Michael E Talkowski; Harrison Brand; Maëlle Perrocheau; Charles Simpson; Christopher Jett; Matthew R Stone; Florie Charles; Colby Chiang; Stacey N Lynch; Nabila Bouatia-Naji; Francesca N Delling; Lisa A Freed; Christophe Tribouilloy; Thierry Le Tourneau; Hervé LeMarec; Leticia Fernandez-Friera; Jorge Solis; Daniel Trujillano; Stephan Ossowski; Xavier Estivill; Christian Dina; Patrick Bruneval; Adrian Chester; Jean-Jacques Schott; Kenneth D Irvine; Yaopan Mao; Andy Wessels; Tahirali Motiwala; Michel Puceat; Yoshikazu Tsukasaki; Donald R Menick; Harinath Kasiganesan; Xingju Nie; Ann-Marie Broome; Katherine Williams; Amanda Johnson; Roger R Markwald; Xavier Jeunemaitre; Albert Hagege; Robert A Levine; David J Milan; Russell A Norris; Susan A Slaugenhaupt
Journal:  Nature       Date:  2015-08-10       Impact factor: 49.962

View more
  2 in total

1.  Sex Differences in Coronary Artery Disease and Diabetes Revealed by scRNA-Seq and CITE-Seq of Human CD4+ T Cells.

Authors:  Ryosuke Saigusa; Jenifer Vallejo; Rishab Gulati; Sujit Silas Armstrong Suthahar; Vasantika Suryawanshi; Ahmad Alimadadi; Jeffrey Makings; Christopher P Durant; Antoine Freuchet; Payel Roy; Yanal Ghosheh; William Pandori; Tanyaporn Pattarabanjird; Fabrizio Drago; Angela Taylor; Coleen A McNamara; Avishai Shemesh; Lewis L Lanier; Catherine C Hedrick; Klaus Ley
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

2.  The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits.

Authors:  Sarajo Kumar Mohanta; Christian Weber; Changjun Yin; Andreas J R Habenicht
Journal:  Clin Transl Med       Date:  2022-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.